Profile
Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring, and treatment of lung cancer. OXcan's multidisciplinary team invented a liquid biopsy blood test developed via cutting-edge proteomics and machine learning that can detect lung cancers early enough when they can still be cured. Fully integrated with existing clinical pathways for accelerated deployment and collaborating with 10+ leading centres of excellence across three continents, this blood test can be conducted in an affordable, minimally invasive, and routine manner in large populations with standard equipment in any diagnostics facility at 1/10th of the cost compared to conventional approaches.
This integrated approach has demonstrated the ability to detect early-stage lung cancer at >90% sensitivity (compared to 20-48% in leading liquid biopsy competitors) and >90% specificity, with a first peer-reviewed manuscript on the analytical portion of this pipeline published in iScience, Cell Press. OXcan is moving forward with detecting multiple other cancer types in parallel to further scale.
Website
Contact
-
Dr. Peter Jianrui Liu, MD, DPhil, Chief Executive OfficerTel: +1 403-305-2478Email: p.liu@oxcan.org
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for improved…
-
Altis Labs is a computational imaging company advancing precision medicine. The company believes that medical imaging…
-
CCRM is a Canadian public-private partnership established with seed funding by the Government of…
-
The City of Brampton Economic Development Office provides business connections, site selection services and access to…
-
Mississauga's life sciences sector is a thriving hub of innovation and growth. With a highly skilled workforce and…
-
Clinical Trials Ontario (CTO) is a leading organization in the clinical trials community dedicated to…
-
Covar Pharmaceuticals delivers customized services for pharmaceutical development of new or existing drugs, novel…
-
Custom Biologics provides regulatory compliant potency testing and assay services for all phases of biotherapeutic drug…
-
Esphera SynBio is a pre-clinical company developing the next generation of exosome-based therapeutics. Their…
-
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative solutions…
-
HDAX Therapeutics is pioneering best-in-class therapeutics for neurological and cardiovascular diseases. Leveraging its…
-
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics, such…
-
Muse is pioneering brain health through its industry-leading EEG…
-
Hamilton’s Economic Development Office (Invest in Hamilton) is the central point of contact for business assistance,…
-
JN Nova Pharma is developing novel therapeutics to address a particular group of Long COVID patients, who…
-
Kingston Economic Development's aim is to support life sciences companies looking to enter the Canadian market and…
-
Life Sciences Ontario is a not-for-profit organization that represents and promotes Ontario’s vibrant and diverse life…
-
Lumerate is a Toronto-based software company specializing in intelligence about the drug development sector and other…
-
Mediphage has developed a proprietary and scalable E. coli-based manufacturing process for the production of ministring…
-
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small molecules…
-
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both…
-
Omnium Global’s vision is to accelerate timelines to market for an impact on global health by helping companies beat…
-
OBIO (Ontario BioScience Innovation Organization) is a Canadian life science accelerator supporting…
-
OICR is Ontario’s Cancer Research Institute. It brings together people from across the province and around the…
-
Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring, and…
-
panCELLa and Pluristyx Company, is an advanced therapy tools and services company whose primary mission is to help…
-
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
-
PlantForm develops and manufactures proteins, antibodies, and vaccines at low cost using its green, plant-based,…
-
PolyAnalytik, Inc. is a CRO laboratory that specializes in…
-
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its platform…
-
PurMinds is a neuro-medicine development and API supply company…
-
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and tissue…
-
Specific Biologics’ mission is to develop therapeutics to treat or cure disease through precision gene editing. Its…
-
SpinUp is the University of Toronto’s wet lab-based, early-stage startup incubator. Located in Mississauga, SpinUp…
-
Stiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and biopharma. Located in…
-
The Synapse Consortium represents Canada’s leading health research and education cluster, including more than 34,000…
-
TheraVac Biologics is developing vaccines and immunotherapies for diseases caused by misfolded protein aggregates and/…
-
Since 2008, TIAP has been building relationships with Toronto’s top research institutions to identify the…
-
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide for…
-
UHN is Canada’s largest and leading research hospital, consisting of six research institutes located…
-
VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small molecules…
-
Virica is a viral vector enhancer company. It has pioneered a new enhancer category called Viral Sensitizers (VSE…